​

Aspira Women's Health (AWH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AWH Stock Forecast

Aspira Women's Health (AWH) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $3.30, with a high of $3.30 and a low of $3.30. This represents a 4025.00% increase from the last price of $0.08.

- $1 $2 $3 $4 $5 High: $3.3 Avg: $3.3 Low: $3.3 Last Closed Price: $0.08

AWH Stock Rating

Aspira Women's Health stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (60.00%), 2 Hold (40.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 2 3 Strong Sell Sell Hold Buy Strong Buy

AWH Price Target Upside V Benchmarks

TypeNameUpside
StockAspira Women's Health4025.00%
SectorHealthcare Stocks 31.06%
IndustryDiagnostics & Research Stocks28.34%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.08$0.08$0.08
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25-1---1
Mar, 25-1---1
Feb, 25-1---1
Jan, 25-11--2
Dec, 24-12--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 01, 2024Ross OsbornCantor Fitzgerald$3.30$3.106.45%4025.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 14, 2024Alliance Global PartnersBuyBuyhold
Apr 01, 2024Cantor FitzgeraldNeutralNeutralhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-2.63$-4.28$-41.66$-1.81$-0.93---
Avg Forecast$-2.35$-4.35$-4.24$-1.92$-1.20$-0.50$-0.26-
High Forecast$-1.81$-3.35$-3.52$-1.83$-1.20$-0.50$-0.26-
Low Forecast$-2.74$-5.07$-5.17$-2.00$-1.20$-0.50$-0.26-
Surprise %11.91%-1.61%882.55%-5.73%-22.50%---

Revenue Forecast

$0 $16M $32M $48M $64M $80M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$4.65M$6.81M$8.18M$9.15M$9.18M---
Avg Forecast$4.53M$6.80M$8.26M$9.58M$11.00M$23.50M$32.66M$75.30M
High Forecast$5.11M$7.67M$9.66M$9.58M$11.00M$23.50M$32.66M$75.30M
Low Forecast$3.73M$5.60M$7.18M$9.58M$11.00M$23.50M$32.66M$75.30M
Surprise %2.57%0.18%-0.97%-4.41%-16.53%---

Net Income Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-17.63M$-31.71M$-21.57M$-16.69M$-13.09M---
Avg Forecast$-21.70M$-40.16M$-29.68M$-16.69M$-11.08M$-4.62M$-2.40M-
High Forecast$-16.71M$-30.92M$-23.75M$-13.35M$-11.08M$-4.62M$-2.40M-
Low Forecast$-25.30M$-46.83M$-35.62M$-20.03M$-11.08M$-4.62M$-2.40M-
Surprise %-18.75%-21.05%-27.32%-18.18%---

AWH Forecast FAQ

Is Aspira Women's Health stock a buy?

Aspira Women's Health stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Aspira Women's Health is a favorable investment for most analysts.

What is Aspira Women's Health's price target?

Aspira Women's Health's price target, set by 5 Wall Street analysts, averages $3.3 over the next 12 months. The price target range spans from $3.3 at the low end to $3.3 at the high end, suggesting a potential 4025.00% change from the previous closing price of $0.08.

How does Aspira Women's Health stock forecast compare to its benchmarks?

Aspira Women's Health's stock forecast shows a 4025.00% upside, outperforming the average forecast for the healthcare stocks sector (31.06%) and outperforming the diagnostics & research stocks industry (28.34%).

What is the breakdown of analyst ratings for Aspira Women's Health over the past three months?

  • April 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Aspira Women's Health’s EPS forecast?

Aspira Women's Health's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.5, marking a -46.24% decrease from the reported $-0.93 in 2024. Estimates for the following years are $-0.26 in 2026, and $0 in 2027.

What is Aspira Women's Health’s revenue forecast?

Aspira Women's Health's average annual revenue forecast for its fiscal year ending in December 2025 is $23.5M, reflecting a 155.94% increase from the reported $9.18M in 2024. The forecast for 2026 is $32.66M, and $75.3M for 2027.

What is Aspira Women's Health’s net income forecast?

Aspira Women's Health's net income forecast for the fiscal year ending in December 2025 stands at $-4.617M, representing a -64.74% decrease from the reported $-13.094M in 2024. Projections indicate $-2.401M in 2026, and $0 in 2027.